Adobe stock slips on Jefferies downgrade as AI payoff questioned — what to watch next

Adobe stock slips on Jefferies downgrade as AI payoff questioned — what to watch next

New York, Jan 5, 2026, 20:40 EST — Market closed

  • Jefferies downgraded Adobe to “hold” from “buy” and cut its price target to $400 from $500, citing a lack of clear AI-driven acceleration. 1
  • Adobe shares ended down 0.5% at $331.56, after dipping to $327.51 earlier in the session.
  • The next major catalysts include the U.S. December jobs report on Jan. 9 and Adobe’s fiscal Q1 earnings call on March 12. 2

Adobe (ADBE.O) shares slipped on Monday after Jefferies downgraded the Photoshop maker to “hold,” arguing that the company’s push to monetise new artificial intelligence tools is not yet translating into faster growth. The stock ended down 0.5% at $331.56. 1

The downgrade matters now because investors are re-pricing software stocks around a simple question: will generative AI add incremental subscription revenue, or pressure the value of traditional application licences? For Adobe, which has leaned on Creative Cloud subscriptions for years, that debate is moving from product demos to revenue math. 1

Jefferies analyst Brent Thill wrote that “any contribution boost from AI has yet to show up,” and said he still sees “no AI inflection” — a clear turn toward faster growth — in the company’s outlook. 1

Jefferies lowered its price target, an analyst’s estimate of where shares could trade over the next 12 months, to $400 from $500, according to reports of the note. In the same shift in software calls, the broker upgraded IBM to “buy,” and IBM shares finished up about 1.2%. 1

The firm pointed to rising competition at the lower end of Adobe’s market, where casual users can choose from a growing list of cheaper, AI-enabled tools. Jefferies said Adobe’s franchise remains better defended among professional creators who rely on deeper editing features and workflow integration. 3

Adobe last month forecast fiscal 2026 revenue of $25.90 billion to $26.10 billion, above Wall Street estimates, and highlighted stronger demand for its design software alongside growing engagement with AI features. The company also said it would buy Semrush for $1.9 billion to strengthen its advertising offering. 4

On Monday, Adobe traded between $327.51 and $334.37, leaving the session low near $328 as a near-term reference point for chart-focused traders. A move back above $334 would put the stock near its best levels of the day.

The risk for bulls is that AI becomes more of a substitute than an add-on, pulling casual users away and forcing tougher pricing decisions. A broader pullback in marketing and creative budgets would also threaten near-term subscription growth, even if Adobe’s core customer base holds up. 3

Macro data could complicate the picture this week. The U.S. December employment report is due on Friday, Jan. 9, and shifts in rate expectations often spill into high-multiple software stocks. 2

For Adobe, the next company-specific checkpoint is its first-quarter fiscal 2026 earnings call on March 12. Investors will be watching for updates on subscription momentum and annual recurring revenue (ARR), a measure that annualises subscription sales, along with any clearer signals that paid AI features are lifting revenue. 5

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Halliburton stock jumps nearly 8% on Venezuela jolt as oil-services rally takes hold
Previous Story

Halliburton stock jumps nearly 8% on Venezuela jolt as oil-services rally takes hold

Nike stock rises 2% as UBS survey shows brand strength improving; investors eye March earnings
Next Story

Nike stock rises 2% as UBS survey shows brand strength improving; investors eye March earnings

Go toTop